
Institute for Prostate Cancer
About Institute for Prostate Cancer
Data last updated:
Institute for Prostate Cancer is a private not for profit company based in Pune, Maharashtra, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 22 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U84120PN2011PTC141427. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dattatraya Chintaman Joglekar and Aarti Mahendra Upadhye.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune Cantonment Mundhwa, Maharashtra, India – 411036.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Institute for Prostate Cancer has one previous CIN (Corporate Identification Number): U85100PN2011NPL141427. The current CIN is U84120PN2011PTC141427, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U84120PN2011PTC141427 | Current |
| U85100PN2011NPL141427 | Previous |
Contact details
Institute for Prostate Cancer's registered office is in Pune, Maharashtra.
- Registered AddressPune Cantonment Mundhwa, Maharashtra, India – 411036
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Institute for Prostate Cancer is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Institute for Prostate Cancer, buy the company report.
Financials of Institute for Prostate Cancer
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Institute for Prostate Cancer, buy the company report.
Board of directors of Institute for Prostate Cancer
Institute for Prostate Cancer has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dattatraya Chintaman Joglekar Also directs: Kalyani Agro Corporation Ltd, Vishwasarh Finance Private Limited, Elan Power Development and Mining Private Limited and 5 more | Director | 01 Jan 2021 | 5 Years 10 Months | Current |
| Aarti Mahendra Upadhye | Director | 01 Jan 2021 | 5 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Institute for Prostate Cancer are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Institute for Prostate Cancer; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Institute for Prostate Cancer has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Institute for Prostate Cancer, buy the company report.
Recent activity
Institute for Prostate Cancer has 12 board changes on record since 2011: 7 appointments and 5 cessations. The latest: Ashutosh Kumar Tewari ceased to be Director on 27 Aug 2024.
3 earlier events are in the company report.
Frequently asked questions
Institute for Prostate Cancer is an active private not for profit company based in Pune, Maharashtra, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 22 November 2011 (15+ years old) and is registered under CIN U84120PN2011PTC141427.
Institute for Prostate Cancer has 2 current directors:
- Dattatraya Chintaman Joglekar - Director
- Aarti Mahendra Upadhye - Director
The latest financial statements of Institute for Prostate Cancer on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Institute for Prostate Cancer has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Institute for Prostate Cancer is U84120PN2011PTC141427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Institute for Prostate Cancer was incorporated on 22 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Pune.
Ashutosh Kumar Tewari ceased to be Director on 27 Aug 2024. Aarti Mahendra Upadhye was appointed as Director on 01 Jan 2021. Dattatraya Chintaman Joglekar was appointed as Director on 01 Jan 2021. Institute for Prostate Cancer has 12 board changes on record in total.
The registered office of Institute for Prostate Cancer is at Pune Cantonment Mundhwa, Maharashtra, India – 411036.
Institute for Prostate Cancer operates in the healthcare industry, in the oncology clinics and cancer treatment segment.
The compliance status of Institute for Prostate Cancer is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.

